Page 7 - Subject Expert News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New Delhi: India's drug controller Drugs Controller General of India(DCGI) has approved Serum Institute of India's 'Covishield' and Bharat Biotech's

URL copied Covishield, Covaxin get govt's nod Drug Controller General of India (DCGI) on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use against coronavirus. The development, eleven months after the first case of deadly coronavirus was detected in India, has paved the way for their roll-out and administration to millions. The vaccine will be first offered to one crore healthcare workers, along with two crore frontline and essential workers and 27 crores elderly, mostly above the age of 50 years with co-morbidities. The...

SII and Bharat Biotech vaccines have to be administered in two doses

Dalal Street Week Ahead: Here are 10 key factors that will keep the traders busy Rusmik Oza of Kotak Securities expects the Nifty50 to go somewhere mid way of the 14,000 to 15,000 range in January. Sunil Shankar Matkar January 03, 2021 / 08:21 AM IST The positive global cues helped the market gain momentum after consolidation seen in the previous week, and close above psychological 14,000 mark on the Nifty50 for the week ended January 1, 2021. The signing of second stimulus package by the United States, the approval for Brexit deal by the Europ...

COVID-19 vaccines of SII, Bharat Biotech approved for restricted use in emergency situation ANI | Updated: Jan 03, 2021 11:36 IST New Delhi [India], January 3 (ANI): COVID-19 vaccines of Serum Institue of India and Bharat Biotech have been granted permission for restricted use in emergency situation, said Drugs Controller General of India (DCGI) on Sunday. "After adequate examination, CDSCO has decided to accept the recommendations of the Expert Committee and accordingly, vaccines of M/s Serum and M/s Bharat Biotech are being approved for restricted use ...